Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna H Boerwinkle

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2024
The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down's syndromeAnna H Boerwinkle, Julie K Wisch, Benjamin L Handen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 6, 2023
Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40Julie K Wisch, Brian A Gordon, Anna H Boerwinkle, et al.
The Lancet. Neurology|December 14, 2022
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional studyAnna H Boerwinkle, Brian A Gordon, Julie Wisch, et al.
The Lancet. Neurology|July 24, 2021
Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional studyAnne M Fagan, Rachel L Henson, Yan Li, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 19, 2026
Brain volume trajectories in Down syndrome and autosomal dominant Alzheimer's diseaseJames T Kennedy, Julie K Wisch, Anna H Boerwinkle, et al.
The Lancet. Neurology|April 17, 2024
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional studyJulie K Wisch, Nicole S McKay, Anna H Boerwinkle, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2024
The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down's syndromeAnna H Boerwinkle, Julie K Wisch, Benjamin L Handen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 6, 2023
Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40Julie K Wisch, Brian A Gordon, Anna H Boerwinkle, et al.
The Lancet. Neurology|December 14, 2022
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional studyAnna H Boerwinkle, Brian A Gordon, Julie Wisch, et al.
The Lancet. Neurology|July 24, 2021
Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional studyAnne M Fagan, Rachel L Henson, Yan Li, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 19, 2026
Brain volume trajectories in Down syndrome and autosomal dominant Alzheimer's diseaseJames T Kennedy, Julie K Wisch, Anna H Boerwinkle, et al.
The Lancet. Neurology|April 17, 2024
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional studyJulie K Wisch, Nicole S McKay, Anna H Boerwinkle, et al.
Pageof 2